B. Niego

发表

Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo

R. Medcalf, P. Daniel, A. Samson, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Fabrication of complex PDMS microfluidic structures and embedded functional substrates by one-step injection moulding

Arnan Mitchell, Khashayar Khoshmanesh, Be'eri Niego, 2016 .

Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers.

F. Caruso, Shuaijun Pan, Yi Ju, 2022, ACS applied materials & interfaces.

Plasmin-Dependent Modulation of the Blood–Brain Barrier: A Major Consideration during tPA-Induced Thrombolysis?

R. Medcalf, B. Niego, Be’eri Niego, 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke

R. Medcalf, B. Niego, D. Draxler, 2019, Front. Immunol..

Applications of Nanotechnology in the Diagnosis and Therapy of Stroke

D. Howells, C. Hagemeyer, B. Sutherland, 2019, Seminars in Thrombosis and Hemostasis.

LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH

C. Sobey, R. Medcalf, B. Broughton, 2017, Fluids and Barriers of the CNS.

t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions

David R. Croucher, D. Croucher, L. Pedersen, 2014, Brain Research.

Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.

R. Medcalf, B. Niego, P. Coughlin, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Assessment of the epi-pericardial fibrotic substrate by collagen-targeted probes

C. Hagemeyer, B. Niego, P. Donnelly, 2022, Scientific Reports.

A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury.

R. Medcalf, P. Crack, A. Samson, 2009, Blood.

Targeting shear gradient activated von Willebrand factor by the novel single-chain antibody A1 reduces occlusive thrombus formation in vitro

Hugo J Albers, C. Hagemeyer, A. D. van der Meer, 2020, Haematologica.

t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes.

R. Medcalf, A. Turnley, B. Niego, 2012, Blood.

Collagen‐Targeted Peptides for Molecular Imaging of Diffuse Cardiac Fibrosis

C. Hagemeyer, B. Niego, P. Donnelly, 2021, Journal of the American Heart Association.

Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin

R. Medcalf, A. Samson, B. Niego, 2011, Brain Research.

Valproic acid selectively increases vascular endothelial tissue‐type plasminogen activator production and reduces thrombus formation in the mouse

R. Medcalf, S. Jern, S. Jackson, 2016, Journal of thrombosis and haemostasis : JTH.

The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis

R. Medcalf, S. Petratos, F. Alderuccio, 2016, PloS one.

Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin

R. Medcalf, N. Lee, B. Niego, 2017, PloS one.

A novel ex vivo approach for measuring plasminogen activation upon established plasma clots

R. Medcalf, C. Hagemeyer, B. Niego, 2022, Research and practice in thrombosis and haemostasis.

Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities

C. Hagemeyer, B. Niego, E. Westein, 2019, Front. Cardiovasc. Med..

Effective treatment of mouse metastatic prostate cancer by low electric field enhanced chemotherapy

R. Korenstein, B. Niego, Y. Keisari, 2006, The Prostate.

Molecular Imaging of Atrial Myopathy: Towards Early AF detection and Non-invasive Disease Management.

C. Hagemeyer, S. Lal, B. Niego, 2020, Trends in cardiovascular medicine.

Studies into the interaction between the plasminogen activating system and the blood-brain barrier

B. Niego, Be’eri Niego, 2013 .

Tissue‐type plasminogen activator requires a co‐receptor to enhance NMDA receptor function

David R. Croucher, D. Croucher, D. Lawrence, 2008, Journal of neurochemistry.

Two conserved regions within the tissue‐type plasminogen activator gene promoter mediate regulation by brain‐derived neurotrophic factor

A. Tjärnlund-Wolf, R. Medcalf, P. Daniel, 2007, The FEBS journal.

Improved method for the preparation of a human cell-based, contact model of the blood-brain barrier.

Be'eri Niego, Robert L Medcalf, R. Medcalf, 2013, Journal of visualized experiments : JoVE.

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single‐Chain Antibody Specific for Activated GPIIb/IIIa

K. Peter, R. Medcalf, C. Hagemeyer, 2017, Journal of the American Heart Association.

Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination

A. Harvey, S. Strittmatter, Y. Sekine, 2019, The Journal of Neuroscience.

Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement

T. Woodruff, R. Medcalf, Z. McQuilten, 2020, Frontiers in Neurology.

Modulation of an in vitro model of the blood brain barrier (BBB) by tissue-type plasminogen activator (t-PA) involves plasmin-mediated changes in the actin cytoskeleton and activation of the Rho-kinase pathway in astrocytes

R. Medcalf, A. Turnley, B. Niego, 2011 .

An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice

F. Caruso, M. Cooper, K. Sourris, 2023, Advanced materials.